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Summary
A rise in cytosolic Ca2+ concentration is used as a key
activation signal in virtually all animal cells, where it
triggers a range of responses, including neurotrans-
mitter release, muscle contraction, and cell growth
and proliferation [1, 2]. A major route for Ca2+ influx is
through store-operated Ca2+ channels. One important
intracellular target for Ca2+ entry through store-oper-
ated channels is the mitochondrion, which increases
aerobic metabolism and ATP production after Ca2+
uptake. Here, we reveal a novel feedback pathway
whereby pyruvic acid, a critical rate-limiting substrate
for mitochondrial respiration, increases store-oper-
ated entry by reducing inactivation of the channels.
Importantly, the effects of pyruvic acid are manifest
at physiologically relevant concentrations and mem-
brane potentials. The reduction in the inactivation
of calcium release-activated calcium (CRAC) channels
by pyruvate is highly specific in that it is not mimicked
by other intermediary metabolic acids, does not re-
quire its metabolism, is independent of its Ca2+ buffer-
ing action, and does not involve mitochondrial Ca2+
uptake or ATP production. These results reveal a new
and direct link between intermediary metabolism and
ion-channel gating and identify pyruvate as a potential
signaling messenger linking energy demand to cal-
cium-channel function.
Results and Discussion
Ca2+ entry through store-operated calcium release-
activated calcium (CRAC) channels is rapidly taken up
by mitochondria [3, 4], stimulating ATP production
through activation of key Ca2+-dependent rate-limiting
enzymes of the Krebs cycle [5, 6]. In turn, by buffering
cytoplasmic Ca2+, mitochondria reduce Ca2+-depen-
dent inactivation of CRAC channels and thus maintain
channel activity [7, 8]. Not all of the effects of mitochon-
dria on CRAC channels can be explained by Ca2+ buffer-
ing, however [9], and it is possible that mitochondrially-
derived signals might help control this ubiquitous
Ca2+-entry pathway [4], as has been suggested for insu-
lin secretion and Na+-channel activity [10, 11]. Here, we
have tested this idea by examining the effects of numer-
ous intermediary metabolites on CRAC-channel activity.
*Correspondence: anant.parekh@dpag.ox.ac.ukCRAC channels exhibit Ca2+-dependent rapid inacti-
vation, which develops within milliseconds and is trig-
gered by the build-up of a microdomain of elevated
Ca2+ beneath each open channel [12–14]. Rapid inactiva-
tion is a general feature of CRAC channels expressed in
different cell types [15]. Figure 1 compares the rate and
extent of rapid inactivation in the presence of different
Ca2+ chelators. After whole-cell dialysis of an RBL-1
cell with a pipette solution containing a strong buffer
(10 mM ethyleneglycol-bis(b-aminoethyl)-N,N,N0,N0-
tetraacetic acid [EGTA]) and the sarcoplasmic or endo-
plasmic reticulum Ca2+-ATPase pump blocker thapsi-
gargin (2 mM) to empty stores, ICRAC developed slowly
(Figure 1A). The characteristic current-voltage (I-V) rela-
tionship, taken at steady state, is shown in Figure 1B.
Upon stepping to 2120mV (from a holding potential of
0mV), ICRAC initially increased but then declined substan-
tially during the pulse (Figure 1C), revealing rapid inacti-
vation. Inactivation was a double-exponential process,
with time constants ofw10 andw100 milliseconds [13,
14]. Inactivation was much less pronounced at 240mV
(Figure 1C),where the driving force forCa2+ influx through
the channels is reduced. Aggregate data over the voltage
range of240mV to2120mV is shown in Figure 1J and the
kinetics of inactivation at2120mV is shown in Figure 1K.
After dialysis with the faster Ca2+ chelator 1,2-bis(2-ami-
nophenoxy)ethane-N,N,N0,N0-tetraacetic acid (BAPTA),
ICRAC developed at a similar rate and extent to that of
EGTA (Figures1D and 1E),but rapid inactivation was con-
siderably less (Figures 1F and 1J; p < 0.01 for each point
between 260mV and 2120mV). Inactivation kinetics
were similar between BAPTA and EGTA (Figure 1K).
Rapid inactivation in a mixture of EGTA and BAPTA
(5 mM each; Figures 1G–1I) lay between 10 mM EGTA
and 10 mM BAPTA (Figure 1J).
To test whether metabolic signals regulated CRAC
channels, we compared rapid inactivation in control cells
(dialyzed cells with 5 mM EGTA and 2mM thapsigargin)
with cells dialyzed with 5 mM EGTA, 2mM thapsigargin,
and 5 mM of different intermediary metabolites. Inclu-
sion of pyruvic acid had quite significant effects on
CRAC-channel activity. Although the whole-cell current
developed similarly under both conditions (Figure 2A)
and with broadly similar I-V curves (Figure 2B), pyruvate
dramatically reduced the extent of rapid inactivation
(Figure 2C), over a range of voltages (Figure 2D; p <
0.01 for each voltage). The time constants of rapid inac-
tivation were unaffected by pyruvate (Table S1 in the
Supplemental Data available online).
The concentration of pyruvic acid in nonstimulated
cells isw0.5 mM [16], but it can double upon stimulation
[16]. Hence pyruvate concentrations in the low millimolar
range are likely to occur physiologically. To see whether
these concentrations impacted rapid inactivation, we in-
cluded different concentrations of pyruvate (0.1–5 mM)
in the pipette solution and measured the extent of
rapid inactivation at 2120mV (Figure 2E). The relation-
ship could be fitted with a Hill-type equation, yielding
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1077Figure 1. Rapid Ca2+-Dependent Inactivation
of ICRAC
Panels depict whole-cell recording with (A–C)
10 mM EGTA in the patch pipette, (D–F)
10 mM BAPTA, and (G–I) a mixture of 5 mM
EGTA and 5 mM BAPTA. (A), (D), and (G)
plot the development of ICRAC versus whole-
cell recording time; (B), (E), and (H) show
the current-voltage relationship taken when
each current had reached steady state (mea-
sured at 280mV from voltage ramps span-
ning from 2100mV to +100mV in 50 ms). (C),
(F), and (I) show the time course of rapid
inactivation at 2120mV and 240mV. To
evoke rapid inactivation, cells were clamped
at 0mV, and then 250 msec hyperpolarizing
steps were applied to the voltages indicated.
(J) plots aggregate data for the conditions
shown (each point represents 9 cells for
EGTA, 9 cells for BAPTA, and 5 cells for
EGTA plus BAPTA). The y axis indicates the
percent of fast inactivation, determined by
measurement of the current remaining at
the end of each pulse divided by the peak
amplitude (1 ms after the onset of the pulse).
Error bars are contained within each symbol.
For all voltages except 240mV, p < 0.01 be-
tween EGTA and BAPTA. In (K), inactivation
time constants are plotted at 2120mV for
each chelator (9 cells for EGTA, 9 cells for
BAPTA, and 5 cells for EGTA plus BAPTA).
There were no significant differences be-
tween the fast or slow time constants for each
condition. Error bars indicate the standard
error of the mean.a half-maximal pipette concentration (EC50) ofw1.6 mM.
The effects of pyruvic acid were discernible as soon as
ICRAC started to develop, which was generally within
50–100 s of the onset of whole-cell recording. At these
times, pyruvic acid would not have equilibrated between
the patch pipette and the cytosol, and the latterconcentration would be considerably lower than that in
the pipette. We estimated the rate of diffusion of pyruvic
acid into the cell [17] (Figure 2F; calculated for a pipette
concentration of 5 mM). After 50–100 s, cytoplasmic
pyruvic acid would bew1 mM, well within the physiolog-
ical range. This estimation assumes that pyruvic acid isFigure 2. Pyruvate Dramatically Reduces
Ca2+-Dependent Rapid Inactivation of CRAC
Channels
(A) shows ICRAC development after dialysis
with EGTA and pyruvate, (B) shows the
steady-state current-voltage relationship,
and (C) shows the rate and extent of rapid
inactivation, for both 5 mM EGTA and 5 mM
EGTA plus pyruvate (with thapsigargin in
both cases). Aggregate data is summarized
in (D) (7 cells each for each condition; p <
0.01 between points over the entire range;
error bars are contained within the symbols).
(E) shows the dependence of inactivation on
pyruvate concentration. The data could be fit-
ted with a Hill-type equation, yielding a Hill
coefficient of w1 and KD of 1.6 mM (4 cells
for each point). (F) plots the predicted rise
in cytosolic pyruvate concentration after dial-
ysis with 5 mM pyruvate. An average capaci-
tance of 15 pF and an average series re-
sistance of 10 Megaohms were used. Error
bars indicate the standard error of the mean.
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1078Figure 3. Neither Mitochondrial Ca2+ Buffer-
ing nor ATP Production Mediate the Effects
of Pyruvic Acid
(A) Inclusion of ruthenium red (100 mM) in
the pipette failed to reverse the effects of
pyruvate on rapid inactivation (4 cells for
each condition).
(B) The effects of pyruvate were not mimicked
by a variety of pyruvate-derived intermediary
metabolites (4–7 cells per bar).
(C) Inhibition of mitochondrial ATP synthesis
with oligomycin (1 mg/ml; 15 min pretreat-
ment) failed to reverse the effects of pyruvate
(6 cells for each condition).
(D) Raising Mg-ATP (to 10 mM) was less
effective than pyruvate (5 cells for each con-
dition).
(E) Plot of the time course of inward (at
280mV) and outward (at +80mV) currents af-
ter dialysis with 5 mM Na ATP/1 mM MgCl2
(w3.8 mM free ATP;w30 mM free Mg2+). After
w220 s, a large outward current developed,
accompanied by a smaller inward one.
(F) Plot of the current-voltage relationship
taken at 546 s in (E).
(G) Comparison of the time course of rapid inactivation at points ‘‘a’’ and ‘‘b’’ in (E). The traces were scaled to have the same peak amplitude. Note
that less inactivation is seen after the outward current (TRPM7) develops.
Error bars indicate the standard error of the mean.neither metabolized nor removed from the cell but simply
equilibrates between the cytosolic compartment and the
patch pipette. Because pyruvic acid is extensively me-
tabolized, the simulation overestimates the rise of its in-
tracellular concentration, and hence the effects probably
occur at even lower concentrations.
We tested whether the effects of pyruvic acid could
be explained by mitochondrial Ca2+ buffering. However,
dialysis with ruthenium red, an inhibitor of the mitochon-
drial Ca2+-uptake channel and which suppresses mito-
chondrial buffering in RBl-1 cells [8], failed to prevent
the reduction in rapid inactivation evoked by pyruvate
(Figure 3A).
To see whether other intermediary metabolites could
substitute for pyruvate, we tested a range of dicarbox-
ylic and tricarboxylic acids generated from the Krebs
cycle (Figure 3B). Dialysis with 5 mM succinic acid, citric
acid, oxaloacetic acid, or a-ketoglutaric acid were all
much less effective (Figure 3B). Two main intracellular
pathways for pyruvate metabolism are its conversion
to acetyl coenzyme A, which enters the Krebs cycle,
and to phosphoenolpyruvate, which is metabolized to
oxaloacetic acid. Because a variety of Krebs-cycle inter-
mediates and oxaloacetate failed to affect rapid inacti-
vation, pyruvate metabolism by these major pathways
is not necessary for the effects reported here.
Because free ATP can buffer cytoplasmic Ca2+, we
considered that the effects of pyruvate were mediated
through mitochondrial ATP generation. However, inhibi-
tion of the mitochondrial F1-F0ATPsynthase with oligo-
mycin failed to alter the effects of pyruvate on rapid
inactivation (Figure 3C), and the inactivation in pyruvate
and oligomycin was similar to that seen in pyruvate.
Moreover, because the vast majority of intracellular
ATP is in the form of Mg-ATP, we increased Mg-ATP in
the standard pipette solution to 10 mM (free Mg2+,
w0.95 mM; free ATP,w270 mM). However, rapid inacti-
vation was still prominent and was significantly less thanthat seen in the presence of pyruvic acid (Figure 3D;
p < 0.01). Free ATP is normally kept at very low levels in
healthy cells, with the vast majority of ATP being bound
to Mg2+. However, free ATP in the millimolar range is
sometimes used experimentally as a mobile Ca2+ buffer,
so we designed experiments to see whether high levels
of free ATP could affect rapid inactivation of CRAC
channels. Such experiments are complicated because
of the generation of a nonselective cation current that
is activated by low levels of Mg2+/Mg-ATP and is likely
mediated by Ca2+-, Mg2+-, and Cs+-permeable TRPM7
channels [18, 19]. To reduce TRPM7 activation, we
used a pipette solution containing 2 mM Mg-ATP along
with 5 mM Na ATP (free ATP was calculated to be
3.8 mM and free Mg2+ was 30 mM). Under these condi-
tions, development of the TRPM7 current was slightly
delayed, so ICRAC initially activated in relative isolation.
Figure 3E plots the development of inward current (black
circles, measured at280mV) and outward current (white
circles, measured at +80mV) after whole-cell dialysis
with 5 mM EGTA, 5 mM Na-ATP, and 2 mM Mg-ATP.
By 200 s, a time when ICRAC had fully developed, no de-
tectable outward current was present, indicating little
activation of TRPM7. Within 200 s, the extent of rapid
inactivation was considerably more with 5 mM Na-ATP
and 2 mM Mg-ATP than with pyruvate (57.0 6 1.55 for
ATP versus 45 6 2.8% for pyruvate ; p < 0.01), demon-
strating that the effects of pyruvate were not mediated
by an increase in free ATP. Afterw220 s, a clear outward
current developed, and this was accompanied by a small
rise in inward current (Figure 3E). The I-V relationship
(Figure 3F) revealed the prominent outward current at
potentials positive to +50mV, characteristic of TRPM7
channels [18]. Importantly, hyperpolarizing steps to
2120mV at these later time points revealed less rapid
inactivation of the whole-cell current (Figure 3G, which
compares rapid inactivation before and after the devel-
opment of TRPM7, labeled ‘‘a’’ and ‘‘b’’ in Figure 3E).
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1079Figure 4. Effect of Pyruvate on Na+-Conducting CRAC Channels
(A) The graph compares the additional Ca2+-binding ratio provided by various intermediary metabolites against the extent of rapid inactivation.
Points from left to right show 5 mM EGTA (standard) and then 5 mM EGTA plus the following: 5 mM succinate, 5 mM pyruvate, 10 mM Mg-ATP,
5 mM a-ketoglutaric acid, 5 mM Na-ATP, and 5 mM citric acid.
(B and C) Ten millimolars of pyruvate alone failed to activate any resolvable ICRAC, whereas 5 mM EGTA and 5 mM pyruvate evoked robust
current. Aggregate data from experiments as in (B) are summarized in (C) (7 cells for each condition).
(D) In divalent-free external solution, hyperpolarizing pulses from 0mV to 2120mV evoke noninactivating currents in 5 mM EGTA versus 5 mM
EGTA plus 5 mM pyruvate (5 cells each).
(E) Current-voltage relationships for ICRAC in divalent-free solution are shown for a cell dialyzed with 5 mM EGTA alone and for one dialyzed with 5
mM EGTA and pyruvate. A larger outward current was consistently observed in pyruvate-dialyzed cells. The inset shows the outward currents on
an expanded scale.
(F) Mean inward current at 290mV (left-hand panel) and mean outward current at +90mV (right-hand panel) normalized to the size of the corre-
sponding inward current are measured for cells dialyzed with either 5 mM EGTA (6 cells) or 5 mM EGTA plus pyruvate (7 cells).
Error bars indicate the standard error of the mean.We attribute this difference to the contaminating pres-
ence of the noninactivating TRPM7 current, which would
mask the true inactivation of ICRAC. In a previous study,
mitochondrially-derived ATP was claimed to act as a lo-
cal Ca2+ buffer [20], preventing the slow inactivation of
CRAC channels that develops over tens of seconds. In
those experiments, Jurkat T cells were dialyzed with
up to 10 mM Na-ATP in the presence of 10 mM EGTA,
and no precautions were taken to eliminate TRPM7.
Hence those recordings were likely severely contami-
nated by the development of TRPM7, masking the inac-
tivation of CRAC channels [20]. Furthermore, interpreta-
tion of those authors’ findings is complicated by the fact
that the extent of inactivation they reported was very dif-
ferent between 10 mM Mg-ATP and 2 mM Na-ATP [20],
even though free ATP was similar in both cases (w1 and
1.3 mM). Hence it is difficult to see how these effects
could actually be mediated by free ATP. Indeed, we see
no difference in the extent of rapid inactivation between
5 mM Na+-ATP and 2 mM Mg-ATP (56.3 6 1.6%) and
10 mM Mg-ATP (57.2% 6 2.1), where free ATP differs
by more than 10-fold (w3.8 and 0.27 mM, respectively).
Some intermediary metabolic acids like citric acid
bind Ca2+ and thus function as intracellular Ca2+ buffers.
Two arguments suggest that the effects of pyruvate arenot through a Ca2+-buffering action. First, the affinity of
pyruvate for Ca2+ is low (KD ofw12 mM), orders of mag-
nitude below the range of cytosolic Ca2+ rises in most
cells. Second, we calculated the additional exogenous
Ca2+-binding ratio (kB), which reflects the buffering ca-
pacity of each ligand [21], for each metabolic acid. The
kB of the standard pipette solution is dominated by the
5 mM EGTA present, with small contributions from glu-
tamic acid and free ATP (from Mg-ATP). The kB from
each metabolic acid on top of this background is plotted
against the extent of rapid inactivation in Figure 4A. Cit-
rate has a 50-fold greater Ca2+-binding ratio than does
pyruvate, yet it is much less effective in reducing rapid
inactivation. Similarly, increasing free ATP adds more
to the total kB than does 5 mM pyruvate, yet it is less
effective in reducing inactivation. Hence the effect of
pyruvate on rapid inactivation does not correlate with
cytoplasmic Ca2+ buffering.
We considered the possibility that pyruvate evoked
a noninactivating current, developing in parallel with
ICRAC. However, dialysis with up to 10 mM pyruvate
failed to activate a detectable current (Figure 4B; aggre-
gate data in Figure 4C). Moreover, the amplitude of ICRAC
in 5 mM EGTA (22.216 0.17 pA/pF at280mV) was sim-
ilar to that seen in cells dialyzed with 5 mM EGTA and
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1080pyruvate (22.30 6 0.24 pA/pF; p > 0.2). Hence the ef-
fects of pyruvate cannot be explained by the generation
of a non-store-operated current that develops in parallel
with ICRAC.
Collectively, we have found that pyruvate reduces the
rapid inactivation of CRAC channels and it does so with-
out buffering cytosolic Ca2+. Because rapid inactivation
is mediated at the channel itself [13, 22], it is likely that
pyruvate interferes with Ca2+ by either competing at a
binding site on the channel or by modifying the efficacy
of Ca2+ to mediate inactivation. We tested the specificity
of the pyruvate effect on rapid inactivation by using
divalent-free external solution, in which Na+ replaces
Ca2+ as the charge carrier. If pyruvate selectively inter-
feres with Ca2+-dependent rapid inactivation, the Na+
current should be unaffected. Figure 4D shows that
this was the case; hyperpolarization to2120mV evoked
a noninactivating current that was unaffected by 5 mM
pyruvate. Hence pyruvate does not affect channel func-
tion per se; rather it interferes selectively with rapid
inactivation. Close inspection of the current-voltage
relationship in divalent-free solution revealed a slight
change in the outward current (Figures 4E and 4F), hint-
ing at the possibility that pyruvate might indeed bind to
the channels. We conclude that pyruvate competes with
or reduces the efficacy of Ca2+ at the channel. If the
mechanism entails competitive inhibition, then our as-
sessment of the pyruvate effects is likely a significant
underestimate of its true impact because, by necessity,
we record CRAC channels in 10 mM Ca2+, favoring Ca2+
over pyruvate.
Conclusion
We have found that a key metabolic product, pyruvic
acid, can impact the activity of CRAC channels, signifi-
cantly reducing the extent of rapid Ca2+-dependent
inactivation. This would increase the amount of Ca2+
that enters the cell and hence results in more sustained
Ca2+-dependent signaling. Fluctuations in the levels of
intracellular pyruvate, as occurs after changes in anaer-
obic to aerobic metabolism, would therefore provide
a novel means for controlling the extent of Ca2+ influx.
This effect of pyruvate is independent of the generation
of a range of mitochondrially derived products arising
from its metabolism, and it does not involve increased
mitochondrial-Ca2+ buffering or -ATP production and
is independent of pyruvate’s weak Ca2+-binding capac-
ity. Instead, our results suggest that pyruvate interacts
with CRAC channels, reducing the ability of intracellular
Ca2+ to evoke rapid inactivation. These effects were
manifest at pyruvate concentrations of w1 mM, well
within the physiological range. Moreover, the effects of
pyruvate were prominent at potentials negative to
260mV, close to the potential seen in mast cells follow-
ing receptor stimulation (approximately 280mV [14]).
CRAC channels are therefore the first known class of
ion channel that can be regulated by an intermediary
metabolite, thereby providing an important potential
link between energy metabolism and Ca2+ influx.
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